RXO Company Profile and Key Details

RXO, Inc. has 164.93 million shares outstanding. The public float is 135.39 million shares, elevated short interest at 25.11% of float. This equals 14.49 million shares. The short ratio is 8.02 days. Institutional investors hold 111.88% of the float. Insiders own 0.81%. MFN Partners, LP holds 28.11 million shares, Cooper Troy A. has 275.42 thousand shares and Kingshott Adrian has 91.14 thousand shares.

RXO, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $2.31. This means the shares are trading above this model’s fair value.

RXO, Inc. (NYSE:RXO) closed at $19.49 USD, losing -$0.02 (-0.10%) from the previous close of $19.51. The stock is currently mid-range between its 52-week high and low $10.43 and $29.90. With a market capitalization of about $3.21 billion, RXO, Inc. is classified as a mid-cap and shows higher-than-market volatility (beta ~1.99). Key stats such as the average daily volume over the past year has been around 1.81 million shares, volume is running light vs its 52-week average. Headquartered in Charlotte, NC, RXO, Inc. operates in the Industrials sector and the Trucking industry. Led by CEO Drew Wilkerson, the company employs approximately 6,906 people and listed since October 27, 2022. RXO, Inc., headquartered in Charlotte, North Carolina, functions as a freight broker specializing in full truckload transportation services across the United States.

RXO has shown mixed momentum, losing -0.75% over the past week and -15.08% over the past quarter, though year-to-date performance is up 15.82%. Short-term trend indicators are mixed aligned (SMA20 0.96%, SMA50 6.14%, SMA200 0.84%). The stock’s 14-day RSI is 52.75 (neutral), while the ATR of 1.17 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -24.73% below its high and over 49.45% above its low. Average 10-day trading volume of 1.69 million shares is in line with the 3-month average of 1.80 million, indicating normal recent market interest.

The latest quarter delivered EPS of $0.06. The next quarter is forecast at -$0.09. Next year's EPS is expected at $69.84. Analyst sentiment is neutral. Analyst rating data shows there are 6 Strong Buy ratings, 7 Buy ratings, 17 Hold ratings, 6 Sell rating and 1 Strong Sell ratings. Price targets range from $35.00 to $10.00. The high target offers 79.58% upside. The low target suggests -48.69% downside. The mean target is $20.00. This offers 2.62% upside. RXO, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended August 06, 2026, missed forecasts by 67.22%. The prior quarter beat by 0.0%. Over the last six quarters, Apple has recorded several small beats. These include 50.0% in May 07, 2025.

RXO, Inc. trades at a P/E ratio of -31.79, slightly below the S&P 500 average, with a price-to-sales ratio of 0.53 and a price-to-book ratio of 2.2 suggesting the stock is closer to book value. The P/FCF stands at -178.0, also below market averages.

RXO, Inc. (NYSE:RXO) shares are up 15.82% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows RXO, Inc. trading at a premium to the broader market with a P/E of -31.79. Analyst sentiment is cautious, with the majority of ratings in Equal-Weight territory and a mean price target of $21.01, suggesting 7.8% upside. Our AI forecast model points to short-term weakness (-1.39% over two weeks), a medium-term fall (-37.81% over three months), and a longer-term gain (3.85% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that RXO, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -1.39%, with price expected at $19.22 by September 25, 2026, within a range of $17.88 to $20.64 3-Month Outlook: Projected fall of -37.81%, reaching $12.12 by December 10, 2026, with a range of $11.38 to $12.82. 1-Year Outlook: Projected gain of 3.85%, with price at $20.24 by September 10, 2027, within a range of $18.35 to $21.80.